NCT04298957 is a NA clinical trial of Cone biopsy in Cervical Dysplasia, sponsored by University of Aarhus.

Who is sponsoring NCT04298957?

NCT04298957 is sponsored by University of Aarhus.

What drugs are being tested in NCT04298957?

Interventions in NCT04298957: Cone biopsy.

What condition does NCT04298957 study?

NCT04298957 studies Cervical Dysplasia, Cervical Lesion, Cervix Disease.

Is NCT04298957 still recruiting?

NCT04298957 is currently completed. Last updated 18 May 2022.

Last reviewed 2022-05-18 · How we verify

NCT04298957

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

See and Treat in an Outpatient Setting in Women Above 45 Years With Cervical Dysplasia

Completed NA Last updated 18 May 2022

What this trial tests

NA trial testing Cone biopsy in Cervical Dysplasia in 109 participants. Completed in 31 January 2022.

Timeline

13 March 2019

Primary endpoint
30 June 2021

31 January 2022

Quick facts

Lead sponsor	University of Aarhus
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	109
Start date	13 March 2019
Primary completion	30 June 2021
Estimated completion	31 January 2022
Sites	3 locations across Denmark

Drugs / interventions tested

Cone biopsy

Conditions studied

Cervical Dysplasia — all drugs for Cervical Dysplasia →
Cervical Lesion — all drugs for Cervical Lesion →
Cervix Disease — all drugs for Cervix Disease →

Sponsor

University of Aarhus

Who can join

45 and older, female only, with Cervical Dysplasia or Cervical Lesion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study will investigate if implementation of "see and treat" in the outpatient clinic can optimize the diagnosis, clinical follow-up and treatment of older women with positive cervical screening test.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Cervical intraepithelial neoplasia in women with transformation zone type 3: cervical biopsy versus large loop excision.
Gustafson LW, Hammer A, Bennetsen MH, Kristensen CB, et al · · 2022 · cited 24× · PMID 35488417 · DOI 10.1111/1471-0528.17200
'I Want the Whole Package'. Elderly Patients' Preferences for Follow-Up After Abnormal Cervical Test Results: A Qualitative Study.
Kirkegaard P, Gustafson LW, Petersen LK, Andersen B. · · 2020 · cited 11× · PMID 32764891 · DOI 10.2147/ppa.s259095
Implementation of p16/Ki67 dual stain cytology in a Danish routine screening laboratory: Importance of adequate training and experience.
Hammer A, Gustafson LW, Christensen PN, Brøndum R, et al · · 2020 · cited 8× · PMID 32894896 · DOI 10.1002/cam4.3399
DNA-Methylation for Risk-Stratification of Women Without a Fully Visible Transformation Zone at Colposcopy: A Cross-Sectional Study.
Binderup KO, Boers J, Gustafson LW, Andersen B, et al · · 2025 · cited 2× · PMID 40654017 · DOI 10.1111/1471-0528.18288

Verify or expand the search:

Other trials of Cone biopsy

Trials testing the same drug.

NCT06289751 — Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer · Phase 2 · recruiting

Other recruiting trials for Cervical Dysplasia

Currently open trials in the same condition.

NCT05640700 — Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia · recruiting
NCT06452004 — Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC) · NA · active not recruiting
NCT05606133 — Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers · NA · recruiting
NCT05774561 — Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring · recruiting
NCT05051722 — Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer · recruiting

Other University of Aarhus trials

Trials by the same sponsor.

NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04298957 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
Last refreshed: 18 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04298957.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing